However, as diet is likely to be effective by itself, especially in CKD, these authors recommend that xanthine oxidase inhibitors should be considered as the primary class of ULT for patients with CKD, and thus mainly allopurinol and febuxostat. The gene discussed is XDH; the disease is chronic kidney disease.